ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Trading 2.4% Higher – Here’s What Happened

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)’s share price traded up 2.4% during trading on Friday . The company traded as high as $37.11 and last traded at $37.01. 42,172 shares changed hands during trading, an increase of 197% from the average session volume of 14,181 shares. The stock had previously closed at $36.15.

ALPS Medical Breakthroughs ETF Trading Up 2.4%

The stock has a fifty day moving average of $33.36 and a 200 day moving average of $30.59.

Institutional Trading of ALPS Medical Breakthroughs ETF

Hedge funds have recently bought and sold shares of the business. Raymond James Financial Inc. bought a new stake in ALPS Medical Breakthroughs ETF during the second quarter worth $82,000. Rossby Financial LCC bought a new stake in ALPS Medical Breakthroughs ETF during the first quarter worth $147,000. Ally Invest Advisors Inc. bought a new stake in ALPS Medical Breakthroughs ETF during the second quarter worth $200,000. Moran Wealth Management LLC bought a new stake in ALPS Medical Breakthroughs ETF during the second quarter worth $300,000. Finally, Strategic Financial Services Inc. lifted its holdings in ALPS Medical Breakthroughs ETF by 12.7% during the first quarter. Strategic Financial Services Inc. now owns 19,225 shares of the company’s stock worth $548,000 after acquiring an additional 2,163 shares during the period.

ALPS Medical Breakthroughs ETF Company Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.